Comments: NY A02904 | 2019-2020 | General Assembly
Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2019 New York A02904 at this time. |